Mark Dybul
2019
In 2019, Mark Dybul earned a total compensation of $1.9M as Executive Vice Chair at Enochian Biosciences.
Compensation breakdown
| Option Awards | $1,724,100 |
|---|---|
| Salary | $165,000 |
| Total | $1,889,100 |
Dybul received $1.7M in option awards, accounting for 91% of the total pay in 2019.
Dybul also received $165K in salary.
Rankings
In 2019, Mark Dybul's compensation ranked 6,224th out of 13,971 executives tracked by ExecPay. In other words, Dybul earned more than 55.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,224 out of 13,971 | 56th |
Division Manufacturing | 2,334 out of 5,695 | 59th |
Major group Chemicals And Allied Products | 851 out of 2,194 | 61st |
Industry group Drugs | 718 out of 1,880 | 62nd |
Industry Pharmaceutical Preparations | 532 out of 1,392 | 62nd |
Source: SEC filing on February 3, 2021.
Dybul's colleagues
We found three more compensation records of executives who worked with Mark Dybul at Enochian Biosciences in 2019.